iohexol has been researched along with Cancer of Spleen in 2 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krol, JJ | 1 |
| Krol, VV | 1 |
| Dawkins, A | 1 |
| Ganesh, HS | 1 |
| Schott, P | 1 |
| Kurtz, B | 1 |
2 other studies available for iohexol and Cancer of Spleen
| Article | Year |
|---|---|
Case 213: primary splenic angiosarcoma.
Topics: Biopsy; Colonoscopy; Contrast Media; Diagnosis, Differential; Fatal Outcome; Female; Hemangiosarcoma | 2015 |
[Lipoma of the spleen].
Topics: Acute Disease; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Diagnosis, Differential | 2011 |